Page last updated: 2024-08-23

ferric nitrilotriacetate and Prostatic Neoplasms

ferric nitrilotriacetate has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ornstein, DL; Zacharski, LR	1

Other Studies

1 other study(ies) available for ferric nitrilotriacetate and Prostatic Neoplasms

Article	Year
Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells. Nutrition and cancer, 2007, Volume: 58, Issue:1 Topics: Dose-Response Relationship, Drug; Ferric Compounds; Humans; Iron; Iron Chelating Agents; Male; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Nitrilotriacetic Acid; Peptide Fragments; Prostatic Neoplasms; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Trans-Activators; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator	2007

Article

Year

Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells.

Nutrition and cancer, 2007, Volume: 58, Issue:1

Topics: Dose-Response Relationship, Drug; Ferric Compounds; Humans; Iron; Iron Chelating Agents; Male; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Nitrilotriacetic Acid; Peptide Fragments; Prostatic Neoplasms; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Trans-Activators; Tumor Cells, Cultured; Up-Regulation; Urokinase-Type Plasminogen Activator

2007